DexCom (Brazil) Investor Sentiment

D1EX34 Stock  BRL 9.30  0.08  0.85%   
About 61% of DexCom's investor base is looking to short. The analysis of current outlook of investing in DexCom Inc suggests that many traders are alarmed regarding DexCom's prospects. The current market sentiment, together with DexCom's historical and current headlines, can help investors time the market. In addition, many technical investors use DexCom Inc stock news signals to limit their universe of possible portfolio assets.
  
few days ago at news.google.com         
DexCom, Inc. Shares Bought by Charles Schwab Investment Management Inc. - MarketBeat
Google News at Macroaxis
few days ago at news.google.com         
Eagle Asset Management Inc. Sells 1,026,333 Shares of DexCom, Inc. - MarketBeat
Google News at Macroaxis
over a week ago at news.google.com         
Oura Health Oy announced that it has received 75 million in funding from DexCom, Inc. - Marketscreen...
Google News at Macroaxis
over two months ago at news.google.com         
Wall Street SWOT DexCom stock faces headwinds amid CGM market expansion - Investing.com
Google News at Macroaxis
over two months ago at news.google.com         
Dexcom Schedules Third Quarter 2024 Earnings Release and Conference Call for October 24, 2024 at 430...
Google News at Macroaxis
over two months ago at news.google.com         
DexCom Stock Price Down 3.7 percent - MarketBeat
Google News at Macroaxis
over two months ago at news.google.com         
Dexcom executive sells 48,020 in company stock - Investing.com
Google News at Macroaxis
over two months ago at news.google.com         
Is DexCom a Millionaire-Maker Stock - The Motley Fool
Google News at Macroaxis
over three months ago at news.google.com         
Should You Hold DexCom - Yahoo Finance
Google News at Macroaxis
over three months ago at news.google.com         
Envestnet Portfolio Solutions Inc. Buys 547 Shares of DexCom, Inc. - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
DXCM Notice of Investigation Kessler Topaz Meltzer Check, LLP Encourages DexCom, Inc. NASDAQ - Marke...
Google News at Macroaxis
over three months ago at news.google.com         
DexCom stock falls over 38 percent as revenue forecast declines - Medical Device Network
Google News at Macroaxis
over three months ago at news.google.com         
Dexcom cuts guidance as Q2 revenue falls short of estimates shares slump - Investing.com
Google News at Macroaxis
over three months ago at news.google.com         
Commit To Purchase DexCom At 60, Earn 5.5 percent Using Options - Nasdaq
Google News at Macroaxis
over three months ago at news.google.com         
DexCom Price Target Lowered to 120.00 at Morgan Stanley - Defense World
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about DexCom that are available to investors today. That information is available publicly through DexCom media outlets and privately through word of mouth or via DexCom internal channels. However, regardless of the origin, that massive amount of DexCom data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of DexCom news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of DexCom relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to DexCom's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive DexCom alpha.

DexCom Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for DexCom Stock analysis

When running DexCom's price analysis, check to measure DexCom's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DexCom is operating at the current time. Most of DexCom's value examination focuses on studying past and present price action to predict the probability of DexCom's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DexCom's price. Additionally, you may evaluate how the addition of DexCom to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
CEOs Directory
Screen CEOs from public companies around the world
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing